发明名称 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
摘要 Enantiomerically enriched disubstituted tetrahydrofurans, tetrahydrothiophenes, pyrrolidines and cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammatory or immune response. The compounds exhibit this biological activity by acting as PAF receptor antagonists, by inhibiting the enzyme 5-lipoxygenase, or by exhibiting dual activity, i. e., by acting as both a PAF receptor antagonist and inhibitor of 5-lipoxygenase.It has been determined that 5-lipoxygenase activity, oral availability, and stability in vivo (for example, glucuronidation rate) can vary significantly among the optical isomers of the disclosed compounds.
申请公布号 US6201016(B1) 申请公布日期 2001.03.13
申请号 US19950390641 申请日期 1995.02.17
申请人 CYTOMED INCORPORATED 发明人 CAI XIONG;GREWAL GURMIT;HUSSOIN SAJJAT;FURA ABERRA;SCANNELL RALPH;BIFTU TESFAYE
分类号 C07D307/14;C07D471/04;(IPC1-7):A61K31/34;A61K31/38;A61K31/44;A61K31/17 主分类号 C07D307/14
代理机构 代理人
主权项
地址